These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11684130)

  • 1. Analysis of SIV-specific CTL in the rhesus macaque model of AIDS: the use of simian fibroblasts as an alternative source of target cells for chromium release assays.
    Sharpe S; Beer B; Hall G; Dennis M; Norley S; Cranage M
    J Immunol Methods; 2001 Dec; 258(1-2):137-40. PubMed ID: 11684130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
    Vogel TU; Friedrich TC; O'Connor DH; Rehrauer W; Dodds EJ; Hickman H; Hildebrand W; Sidney J; Sette A; Hughes A; Horton H; Vielhuber K; Rudersdorf R; De Souza IP; Reynolds MR; Allen TM; Wilson N; Watkins DI
    J Virol; 2002 Nov; 76(22):11623-36. PubMed ID: 12388723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
    Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
    Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
    J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques.
    Venet A; Bourgault I; Aubertin AM; Kiény MP; Levy JP
    J Immunol; 1992 May; 148(9):2899-908. PubMed ID: 1349322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.
    Kaur A; Daniel MD; Hempel D; Lee-Parritz D; Hirsch MS; Johnson RP
    J Virol; 1996 Nov; 70(11):7725-33. PubMed ID: 8892893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simian immunodeficiency virus envelope V3 cytotoxic T-lymphocyte epitope in rhesus monkeys and its restricting major histocompatibility complex class I molecule Mamu-A*02.
    Watanabe N; McAdam SN; Boyson JE; Piekarczyk MS; Yasutomi Y; Watkins DI; Letvin NL
    J Virol; 1994 Oct; 68(10):6690-6. PubMed ID: 7521921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression.
    Evans DT; Jing P; Allen TM; O'Connor DH; Horton H; Venham JE; Piekarczyk M; Dzuris J; Dykhuzen M; Mitchen J; Rudersdorf RA; Pauza CD; Sette A; Bontrop RE; DeMars R; Watkins DI
    J Virol; 2000 Aug; 74(16):7400-10. PubMed ID: 10906193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex.
    Kuroda MJ; Schmitz JE; Barouch DH; Craiu A; Allen TM; Sette A; Watkins DI; Forman MA; Letvin NL
    J Exp Med; 1998 May; 187(9):1373-81. PubMed ID: 9565630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system.
    Evans DT; Chen LM; Gillis J; Lin KC; Harty B; Mazzara GP; Donis RO; Mansfield KG; Lifson JD; Desrosiers RC; Galán JE; Johnson RP
    J Virol; 2003 Feb; 77(4):2400-9. PubMed ID: 12551977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.
    Newberg MH; Kuroda MJ; Charini WA; Miura A; Lord CI; Schmitz JE; Gorgone DA; Lifton MA; Kuus-Reichel K; Letvin NL
    Virology; 2002 Sep; 301(2):365-73. PubMed ID: 12359438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I.
    Chen ZW; Craiu A; Shen L; Kuroda MJ; Iroku UC; Watkins DI; Voss G; Letvin NL
    J Immunol; 2000 Jun; 164(12):6474-9. PubMed ID: 10843704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
    Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
    Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
    Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.
    Loffredo JT; Sidney J; Wojewoda C; Dodds E; Reynolds MR; Napoé G; Mothé BR; O'Connor DH; Wilson NA; Watkins DI; Sette A
    J Immunol; 2004 Oct; 173(8):5064-76. PubMed ID: 15470050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys.
    Santra S; Schmitz JE; Kuroda MJ; Lifton MA; Nickerson CE; Lord CI; Pal R; Franchini G; Letvin NL
    J Immunol; 2002 Feb; 168(4):1847-53. PubMed ID: 11823518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.
    Kuroda MJ; Schmitz JE; Charini WA; Nickerson CE; Lord CI; Forman MA; Letvin NL
    J Virol; 1999 Feb; 73(2):1573-9. PubMed ID: 9882363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques.
    Nakamura M; Takahara Y; Ishii H; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T; Matsuoka S
    Microbiol Immunol; 2011 Nov; 55(11):768-73. PubMed ID: 21895748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa.
    Murphey-Corb M; Wilson LA; Trichel AM; Roberts DE; Xu K; Ohkawa S; Woodson B; Bohm R; Blanchard J
    J Immunol; 1999 Jan; 162(1):540-9. PubMed ID: 9886431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.